In an outpatient cohort, over 90% of patients with type 2 diabetes and failure of metformin monotherapy reached their individual HbA1c goal with additional basal insulin at bedtime over several years in association with a reduction of bodyweight as well and without any event of severe hypoglycaemia. This evidence concerns the gene INS and type 2 diabetes mellitus.